Austal Limited wins another construction contract from the U.S. Navy

austal

Austal Limited (ASX: ASB) today announced that the company has secured construction contract by the U.S. Navy to build two additional Combat Ships for the value of approximately US$584 million per ship. The contract includes the construction of Independence class Littoral Combat Ships which are said to be sixteenth and seventeenth in the class.

Under the congressional cost cap, the contract cost reaches to circa $1.6 billion for both the vessels.

Austal CEO, David Singleton said, “This latest order from US Navy is a tremendous endorsement of the Austal LCS platform and further evidence of the important role Austal plays in building the United States Navy.”

To meet the U.S. Navy’s mission requirements as they operate globally, the shipbuilder Austal designs the 127m frigate combat ship in the Austal center for excellence in maritime design located in Henderson, Western Australia. This design is transferred by the company to its U.S. segment Austal USA which then builds the vessel in company-owned built shipyard located in Mobile, Alabama USA. Last month Austal has delivered the future USS Charleston-LCS 18- to the Navy. 

With nine Expeditionary Fast Transport (EPFs) and eight Littoral Combat Ships (LCS) already delivered, Austal is expected to deliver USNS Burlington EPF10 before the end of 2018.  Also, it has been informed that construction of LCS 32 is expected to commence in 2019 while the delivery of LCS 34 is scheduled to occur in mid FY2023.

Austal USA is a part of Austal Limited, a global shipbuilder. Austal USA is a defense prime contractor for markets around the globe. The segment focuses on design, manufacturing and maintenance of commercial and defense vessels. It has built shipyard located in Mobile, Alabama USA.

Despite clutching yet another contract from U.S. Navy, Austal’s share price bled 0.521% to $1.910 on 19 September 2018. The stock has seen a performance change of +17.79% over the past year, while it has been trading at PE of 16.990 x with market capitalization of $675.17 million.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

 

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report